TATVA CHINTAN PHARMA CHEM
Back to All Ratios
|
TATVA CHINTAN PHARMA CHEM Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 47.59 | 45.13 | 67.12 | 49.16 | - |
What is the latest Price to Cash Earnings (PCE) ratio of TATVA CHINTAN PHARMA CHEM ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 47.59 |
| Mar2024 | 45.13 |
| Mar2023 | 67.12 |
| Mar2022 | 49.16 |
| Mar2021 | - |
How is Price to Cash Earnings (PCE) of TATVA CHINTAN PHARMA CHEM Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 47.59 | 5.45 | |
| Mar2024 | 45.13 | -32.76 | |
| Mar2023 | 67.12 | 36.53 | |
| Mar2022 | 49.16 | 0 | |
| Mar2021 | 0 | - | |
Other Financial Ratios of TATVA CHINTAN PHARMA CHEM
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of TATVA CHINTAN PHARMA CHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TATVA CHINTAN PHARMA CHEM | ₹2,718.3 Cr | 0.6% | -5.2% | 70.4% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹138,727.0 Cr | 4.1% | -8% | -3.4% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹116,647.0 Cr | -2% | -3.6% | 20.4% | Stock Analytics | |
| SRF | ₹76,121.9 Cr | 3.6% | -3.1% | -17.4% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹35,689.7 Cr | 2.7% | -7.1% | -20% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹27,284.6 Cr | -1.5% | -22.9% | -33.6% | Stock Analytics | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | 0.6% |
-5.2% |
70.4% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses